m+Medelevator.RU
← Поиск публикаций
Rheumatology (Oxford, England) · 2026

Baseline features and functional outcomes in primary central nervous system vasculitis: development and validation of a prognostic model.

СтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Nehme Ahmad, Sylaja P N, Isabel Clothilde, Capron Jean, Arquizan Caroline, Régent Alexis, Guillon Benoit, Dequatre Nelly, Detante Olivier, Casolla Barbara, Levraut Michael, Gollion Cédric, Kremer Laurent, Lambert Nicolas, Derex Laurent, Humbertjean Lisa, Denier Christian, Kerschen Philippe, Saadoun David, Vannier Stéphane, Sibon Igor, Maarouf Adil, Weisenburger-Lile David, Sellimi Amina, Mazighi Mikael, Lanthier Sylvain, Poppe Alexandre Y, Mathon Bertrand, Boulouis Grégoire, Godard Sophie, Terrier Benjamin, Aouba Achille, Zuber Mathieu, Sundaram Soumya, Paramsivam Naveen, Briant Anaïs, Parienti Jean-Jacques, Touzé Emmanuel, Pagnoux Christian, de Boysson Hubert, Cohort of Patients with PCNSV study group

Аннотация

OBJECTIVES: Few data are available regarding the functional prognosis of adults with primary central nervous system vasculitis (PCNSV). We developed and validated a prognostic model for 12-month functional independence in adults with PCNSV.

METHODS: We conducted a multicentre, international cohort study of adults with PCNSV (COVAC'). The primary end point was functional independence 12 months after the start of corticosteroids or immunosuppressants, defined as a modified Rankin Scale of 0-2. We identified baseline features independently associated with functional independence using multivariable analyses. We assessed discrimination using AUC-ROC and externally validated the model in a geographically distinct, single-centre cohort from India.

RESULTS: Among the 206 patients included with PCNSV (mean age: 48 years; 41% female), 67 (33%) were diagnosed based on a positive biopsy. At 12 months, 135 (66%) patients were functionally independent and 12 (6%) had died. Favourable prognostic factors were ≥1 intracranial stenosis on CT- or MR-angiogram (OR = 2.99, 95% CI: 1.23-7.68) and headache (OR = 2.67, 95% CI: 1.31-5.59). Unfavourable prognostic factors were an altered level of consciousness (OR = 0.09, 95% CI: 0.02-0.31), ≥1 acute brain infarct (OR = 0.12, 95% CI: 0.04-0.33) and cognitive impairment (OR = 0.22, 95% CI: 0.10-0.46). A prognostic model including these five variables had an AUC of 0.80 (95% CI: 0.74-0.87) in the derivation cohort and 0.67 (95% CI: 0.54-0.81) in the validation cohort.

CONCLUSIONS: Baseline clinical and imaging variables may predict 12-month functional independence in adults with PCNSV. These results may support physicians in prognostication and risk stratification of adults with PCNSV.

ИП Урсолов Владлен Сергеевич

ИНН 500118482352 · ОГРНИП 314500117700049

Реквизиты и контакты